Want to know how we craft impactful new partnerships,
keep our clients ahead of emerging issues,
and advance their strategic goals?
Explore our downloadable one-pagers and background material on C&M International,
how we work, and the results we achieve for our clients.
CMI Company Overview
Background on C&M International – who we are, how we work, and our results.
CMI Asia Pacific
Background on CMI's Singapore office and our long track record of impactful work in the Asia-Pacific region.
Our unique history, experience, and expertise in leveraging the Asia-Pacific Economic Cooperation (APEC) forum as the region's premier economic policymaking platform.
CMI Global Health
Our portfolio of initiatives and outcomes on behalf of innovative biopharmaceutical and medical technology companies, industry associations, and public health organizations.
CMI Global Health Ethics & Business Integrity
We help healthcare companies, associations, and systems design and implement ethical business practices and good governance policies to uphold patient trust, attract investment, protect shareholder value, and secure a level playing field across markets.
Future of Health Policy Roadmap
Policy recommendations from C&M International on digital health, health data, and emerging technologies.
Global Health: What's Ahead for 2022: Vaccines
“Global Health: Vaccines” delivers a global perspective on key developments in the area of vaccines, including COVID-19.
Global Health: What's Ahead for 2022: Health Financing
"Global Health: Health Financing" delivers a global perspective on key developments on the horizon for health financing in both the public and private sectors.
Global Health: What's Ahead for 2022: Antimicrobial Resistance
"Global Health: Antimicrobial Resistance" delivers global perspective on key developments on the horizon in the area of antimicrobial resistance.
Global Health: What's Ahead for 2022: Oncology
“Global Health: Oncology” delivers a forecast for 2022 on new approaches to cancer awareness and detection, cancer campaigns and initiatives, as well as the impact of COVID-19 on the field of oncology.
Global Health: What's Ahead for 2022: Women's Health
“Global Health: What’s Ahead for 2022: Women’s Health”, the fifth in CMI’s seven-part forecast series, focuses on the negative impact of COVID-19 on women’s health, which global women’s health initiatives are likely to be renewed in 2022, and global developments in women’s health in both the public and private sectors.
Global Health: What's Ahead for 2022: Rare Diseases
"Global Health: What's Ahead for 2022: Rare Diseases" focuses on the brightening outlook for rare diseases as a result of scientific advances, rising global awareness, regulatory momentum, and attention from institutional payors.
Global Health: What's Ahead for 2022: Digital Health/Artificial Intelligence (AI)
"Global Health: What's Ahead for 2022: Digital Health/Artificial Intelligence (AI)" explores what's on the horizon for digital health innovation, including AI-enabled tools, for both public and private stakeholders using this technology.
Global Health: A Look Ahead At Trends In Seven Key Areas
“Global Health: What’s Ahead” is a compilation of CMI's seven-part forecast series, exploring the important global health trends and challenges that businesses and governments may face this year.
Global Trade & Investment
CMI Supply Chain & Trade Policy
Our unparalleled expertise in leveraging free trade agreements and trade policy to deliver supply chain efficiencies and costs savings.
CMI Sustainability & Environmental Policy
Our work in international policymaking venues on marine debris, environmental issues, and corporate sustainability initiatives.